Economic Evaluation of Once-Weekly Insulin Icodec from Italian NHS Perspective
Icodec represents a new therapeutic option to simplify basal insulin treatment. It also improves the patient's management and his quality of life, without increasing the economic burden for the Italian NHS, while guaranteeing an excellent cost-effectiveness profile.
Authors
- Enrico Torre (ORCID: https://orcid.org/0000-0002-4375-7383)
- Giorgio Lorenzo Colombo (ORCID: https://orcid.org/0000-0002-5790-8891)
- Chiara Martinotti (ORCID: https://orcid.org/0000-0001-6304-9977)
- Luigi Carlo Bottaro
- Giacomo Matteo Bruno (ORCID: https://orcid.org/0000-0003-4571-654X)
- Sergio Di Matteo
Institutions
- University of Pavia (IT)
- Center for Outcomes Research and Clinical Epidemiology (IT)
- University of Genoa (IT)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/ceor.s475461
- Citations
- 7
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.50